Skip to main content
Log in

Value of measurement of C-reactive protein in febrile patients with hematological malignancies

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The maximum serum levels of C-reactive protein (CRP) in 126 patients with hematological malignancies who had 554 febrile episodes were analyzed retrospectively with regard to documented infections and fever of unknown origin. The CRP levels were significantly higher when the blood culture was positive than when it was negative (p=0.002). The CRP levels were significantly higher when the infection focus was identified than when it was not (p=0.010). In patients with fever of unknown origin the CRP was significantly lower than in patients with microbiologically documented infections (p<0.001). Cytotoxic treatment neither reduced nor enhanced the CRP reaction. The serial measurement of CRP is a reliable and readily available means for differentiating between bacterial infections and other causes of fever in patients with hematological malignancies, also during neutropenia and after cytotoxic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bodey GP, Rodriguez V, Chang HY, Narboni G Fever and infection in leukemic patients. Cancer 1978, 41: 1610–1622.

    PubMed  Google Scholar 

  2. Hughes WT, Amstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC, Young LS, Yow MD Guidelines for the use of antimicrobial agents in neutropenic patients with an unexplained fever. Journal of Infectious Diseases 1990, 161: 381–396.

    PubMed  Google Scholar 

  3. Pizzo PA Evaluation of fever in the patient with cancer. European Journal of Cancer and Clinical Oncology 1989, 25, Supplement: 9–16.

    Article  Google Scholar 

  4. O'Hanley P, Easaw J, Rugo H, Easaw S Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital. American Journal of Medicine 1989, 87: 605–613.

    PubMed  Google Scholar 

  5. Dinarello CA, Wolff SM Molecular basis of fever in humans. American Journal of Medicine 1982, 72: 799–819.

    Article  PubMed  Google Scholar 

  6. Grutzmeier S, von Schenck H C-reactive protein during chemotherapy for acute leukemia with special reference to non-infective causes of fever. Medical Oncology and Tumor Pharmacotherapy 1986, 3: 71–75.

    PubMed  Google Scholar 

  7. Starke ID, De Beer FC, Donnelly JP, Catovsky D, Goldman JM, Galton DAG, Pepys MB Serum C-reactive protein levels in the management of infection in acute leukaemia. European Journal of Cancer and Clinical Oncology 1984, 20: 319–325.

    Article  Google Scholar 

  8. Dinarello CA, Cannon JG, Wolff SM New concepts on the pathogenesis of fever. Reviews of Infectious Diseases 1988, 10: 168–189.

    PubMed  Google Scholar 

  9. Ligtenberg PC, Hoepelman IM, Oude Sogtoen GAC, Dekker AW, van der Tweel I, Rozenberg-Arska M, Verhoef J C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients. European Journal of Clinical Microbiology and Infectious Diseases 1991, 10: 25–31.

    Google Scholar 

  10. Schofield KP, Voulgari F, Gozzard DI, Leyland MJ, Beeching NJ, Stuart J C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. Journal of Clinical Pathology 1982, 35: 866–869.

    PubMed  Google Scholar 

  11. Timonen TTT, Koistinen P C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia. European Journal of Cancer and Clinical Oncology 1985, 21: 557–562.

    Article  Google Scholar 

  12. Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. International Journal of Immunopharmacology 1988, 10: 717–728.

    Article  PubMed  Google Scholar 

  13. Kostiala AAI, Kostiala I, Valtonen VV, Teerenhovi L Levels of C-reactive protein in patients with hematologic malignancies. Scandinavian Journal of Infectious Diseases 1985, 17: 407–410.

    PubMed  Google Scholar 

  14. De Bel C, Gerritsen E, de Maaker G, Moolenaar A, Vossen J C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation. Infection 1991, 19: 92–96.

    Article  PubMed  Google Scholar 

  15. Rose PE, Johnson SA, Meakin M, Mackie PH, Stuart J Serial study of C-reactive protein during infection in leukaemia. Journal of Clinical Pathology 1981, 34: 263–266.

    PubMed  Google Scholar 

  16. Toniatti C, Arcone R, Majello B, Ganter U, Arpala G, Ciliberto G Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. Molecular Biology and Medicine 1990, 7: 199–212.

    Google Scholar 

  17. Marinkovic S, Jahreis GP, Wong GG, Baumann H Il-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. Journal of Immunology 1989, 142: 808–812.

    Google Scholar 

  18. Segal R, Mozes E, Yaron M, Tartakovsky B The effects of methotrexate on the production and activity of interleukin-1. Arthritis and Rheumatism 1989, 32: 370–377.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rintala, E., Irjala, K. & Nikoskelainen, J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 11, 973–978 (1992). https://doi.org/10.1007/BF01967785

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967785

Keywords

Navigation